These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 15236647)
1. The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Bousquet J; Bindslev-Jensen C; Canonica GW; Fokkens W; Kim H; Kowalski M; Magnan A; Mullol J; van Cauwenberge P Allergy; 2004; 59 Suppl 77():4-16. PubMed ID: 15236647 [TBL] [Abstract][Full Text] [Related]
2. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review. Bousquet J; Ansótegui I; Canonica GW; Zuberbier T; Baena-Cagnani CE; Bachert C; Cruz AA; González SN; Kuna P; Morais-Almeida M; Mullol J; Ryan DP; Sánchez-Borges M; Valiente R; Church MK Curr Med Res Opin; 2012 Jan; 28(1):131-9. PubMed ID: 22149770 [TBL] [Abstract][Full Text] [Related]
3. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Bousquet J; Van Cauwenberge P; Bachert C; Canonica GW; Demoly P; Durham SR; Fokkens W; Lockey R; Meltzer EO; Mullol J; Naclerio RM; Price D; Simons FE; Vignola AM; Warner JO; ; Allergy; 2003 Mar; 58(3):192-7. PubMed ID: 12653792 [No Abstract] [Full Text] [Related]
4. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review. Bachert C; van Cauwenberge P Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Berger WE; Schenkel EJ; Mansfield LE; Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207 [TBL] [Abstract][Full Text] [Related]
6. The ARGA study with Italian general practitioners: prescriptions for allergic rhinitis and adherence to ARIA guidelines. Maio S; Simoni M; Baldacci S; Angino A; Martini F; Cerrai S; Sarno G; Silvi P; Borbotti M; Pala AP; Bresciani M; Paggiaro PL; Viegi G Curr Med Res Opin; 2012 Oct; 28(10):1743-51. PubMed ID: 22958052 [TBL] [Abstract][Full Text] [Related]
7. A treatment for allergic rhinitis: a view on the role of levocetirizine. Holgate S; Powell R; Jenkins M; Ali O Curr Med Res Opin; 2005 Jul; 21(7):1099-106. PubMed ID: 16004679 [TBL] [Abstract][Full Text] [Related]
8. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Antonicelli L; Micucci C; Voltolini S; Senna GE; Di Blasi P; Visonà G; De Marco R; Bonifazi F Allergy; 2007 Sep; 62(9):1064-70. PubMed ID: 17686109 [TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of desloratadine for the management of allergic disease. Berger WE Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713 [TBL] [Abstract][Full Text] [Related]
10. [ARIA (Allergic Rhinitis and its Impact on Asthma). Achievements in 10 years and future needs in Latin America]. Baena-Cagnani CE; Sánchez-Borges M; Zernotti ME; Larenas-Linnemann D; Cruz AA; González-Díaz SN; Ivancevich JC; Aldrey-Palacios O; Sisul JC; Solé D; Cepeda AM; Jares EJ; Calvo Gil M; Valentin-Rostán M; Yáñez A; Gereda J; Cardona-Villa R; Rosario N; Croce VH; Bachert C; Canonica GW; Demoly P; Passalacqua G; Samolinski B; Schünemann HJ; Yorgancioglu A; Ansotegui IJ; Khaltaev N; Bedbrook A; Zuberbier T; Bousquet J Rev Alerg Mex; 2013; 60(4):184-92. PubMed ID: 24912911 [TBL] [Abstract][Full Text] [Related]
11. Safety evaluation of desloratadine in allergic rhinitis. González-Núñez V; Valero A; Mullol J Expert Opin Drug Saf; 2013 May; 12(3):445-53. PubMed ID: 23574541 [TBL] [Abstract][Full Text] [Related]
12. Comments on Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. Spector S; Wallace D; Nicklas R; Portnoy J; Blessing-Moore J; Bernstein D; Cox L; Oppenheimer J; Lang D; Schuller D; Randolph C; Tilles S; Khan D; Dykewicz M J Allergy Clin Immunol; 2011 Jun; 127(6):1641-2; author reply 1643-5. PubMed ID: 21496893 [No Abstract] [Full Text] [Related]
13. Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective. Bachert C; Jorissen M; Bertrand B; Khaltaev N; Bousquet J B-ENT; 2008; 4(4):253-7. PubMed ID: 19227033 [TBL] [Abstract][Full Text] [Related]
14. Experimental models for the evaluation of treatment of allergic rhinitis. Day JH; Ellis AK; Rafeiro E; Ratz JD; Briscoe MP Ann Allergy Asthma Immunol; 2006 Feb; 96(2):263-77; quiz 277-8, 315. PubMed ID: 16498847 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma. Bachert C; Maspero J J Asthma; 2011 Nov; 48(9):965-73. PubMed ID: 21970671 [TBL] [Abstract][Full Text] [Related]
19. [The place of new antihistamines in allergy management. Apropos of desloratadine]. Sabbah A Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624 [TBL] [Abstract][Full Text] [Related]
20. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Bachert C Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]